These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 28571018)

  • 21. Achievements and Challenges in Anti-Doping Research.
    Bowers LD; Bigard X
    Med Sport Sci; 2017; 62():77-90. PubMed ID: 28571018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Athlete biological passport: longitudinal biomarkers and statistics in the fight against doping.
    Dragčević D; Pandžić Jakšić V; Jakšić O
    Arh Hig Rada Toksikol; 2024 Mar; 75(1):24-31. PubMed ID: 38548376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
    Pitsiladis YP; Durussel J; Rabin O
    Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current strategies of blood doping detection.
    Pottgiesser T; Schumacher YO
    Anal Bioanal Chem; 2013 Dec; 405(30):9625-39. PubMed ID: 23934350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miRNAs: a new generation of anti-doping biomarkers.
    Leuenberger N; Robinson N; Saugy M
    Anal Bioanal Chem; 2013 Dec; 405(30):9617-23. PubMed ID: 24077830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indirect biomarkers of blood doping: A systematic review.
    Krumm B; Saugy JJ; Botrè F; Donati F; Faiss R
    Drug Test Anal; 2024 Jan; 16(1):49-64. PubMed ID: 37160638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of reference materials in doping-control analysis.
    Mackay LG; Kazlauskas R
    Anal Bioanal Chem; 2011 Aug; 401(2):483-92. PubMed ID: 21562740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of biological markers indicative of doping: the athlete biological passport.
    Saugy M; Lundby C; Robinson N
    Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of RNA biomarkers in the antidoping field.
    Loria F; Grabherr S; Kuuranne T; Leuenberger N
    Bioanalysis; 2024; 16(10):475-484. PubMed ID: 38497758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The athlete biological passport.
    Sottas PE; Robinson N; Rabin O; Saugy M
    Clin Chem; 2011 Jul; 57(7):969-76. PubMed ID: 21596947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doping detection in animals: A review of analytical methodologies published from 1990 to 2019.
    Moreira F; Carmo H; Guedes de Pinho P; Bastos ML
    Drug Test Anal; 2021 Mar; 13(3):474-504. PubMed ID: 33440053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ensuring high quality in anti-doping laboratories.
    Boghosian T; Barroso O; Ivanova V; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1591-601. PubMed ID: 22831475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.